Evolent Health, Inc.
EVH
$4.72
-$0.02-0.42%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.50% | 93.79% | -1,956.80% | -4.86% | 69.21% |
| Total Depreciation and Amortization | 0.07% | -59.95% | 118.36% | 2.70% | -1.22% |
| Total Amortization of Deferred Charges | 1.99% | -1.55% | -11.74% | 36.94% | -6.40% |
| Total Other Non-Cash Items | 60.01% | -97.01% | 1,974.78% | -18.86% | -64.58% |
| Change in Net Operating Assets | -120.08% | -131.62% | 420.22% | 80.83% | -157.82% |
| Cash from Operations | -846.34% | -102.02% | 208.63% | 152.13% | -764.49% |
| Capital Expenditure | -6.92% | -113.27% | 638.88% | 85.15% | -360.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 193.40% | -- |
| Cash from Investing | -4.57% | -107.80% | 1,037.61% | 85.52% | -362.32% |
| Total Debt Issued | -- | -- | -89.15% | -- | -100.00% |
| Total Debt Repaid | -- | -- | 31.80% | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 99.61% | -3,031.03% | 99.86% | -144,696.43% | 99.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 100.00% | 58.26% | -0.96% |
| Other Financing Activities | 54.29% | -188.26% | 284.04% | 68.96% | 89.69% |
| Cash from Financing | -176.69% | 95.73% | -122.49% | -368.41% | -108.28% |
| Foreign Exchange rate Adjustments | 53.48% | -161.78% | -11.94% | -142.17% | -460.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -128.23% | -131.71% | 207.80% | 64.99% | -200.53% |